RxDoctor Payments Data

Susan Williams, MD

Internal Medicine · Cleveland, OHNPI 1316058993

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,410 of the $4,957 with a category attached, or 89.0%. Lifescan, Inc. accounts for 89.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $4,442 and has fallen 95.0% since, to $222 in 2025. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,957in general payments, 2019–2025

Across 25 payments — averaging $198.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lifescan, Inc.$4K
  • UCB, Inc.$294
  • Ascendis Pharma Endocrinology Inc$89
  • Amgen$68
  • Dexcom, Inc.$37
  • Novo Nordisk$32
  • plus $17 from 1 others

What the payments were for

  • Consulting fees$4,41089%
  • Travel & lodging$90%
  • Food & beverage$53811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,957 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio →

Medicare billing

Part B allowed, 2024
$35,423
Medicare patients
272
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StrensiqAsfotase Alfa23$3,201,661
Teriparatide67$183,544
CrysvitaBurosumab-Twza16$168,799
ForteoTeriparatide17$89,441
Cinacalcet Hcl26$14,977
JanuviaSitagliptin Phosphate13$11,488
Humalog Kwikpen U-100Insulin Lispro18$9,160
HumalogInsulin Lispro12$2,895
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$2,787
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic36$2,569
SynthroidLevothyroxine Sodium29$1,950
Levothyroxine Sodium64$709
Calcitriol29$485
Glipizide ErGlipizide15$232
Methimazole30$190

Paid to pharmacies, not to this prescriber.

Other internal medicine in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →